GENE ONLINE|News &
Opinion
Blog

2026-06-09|

SEI Investments Company Appoints Sneha Shah as Chief AI Strategist

by GOAI
Share To

SEI Investments Company appointed Sneha Shah as its new Chief AI Strategist on Tuesday, marking a strategic expansion of the firm’s leadership in enterprise artificial intelligence and data management. In this newly created role, Shah oversees the integration of AI technologies across the company’s business units to enhance operational efficiency and data-driven decision-making.

Shah joins the organization with a background in scaling data and technology initiatives within the financial services sector. As Chief AI Strategist, she reports to the company’s executive leadership team and coordinates the development of internal AI frameworks. Her responsibilities include identifying opportunities for automation, refining data governance protocols, and supporting the firm’s broader digital transformation efforts. This appointment follows the company’s recent initiatives to modernize its technological infrastructure and increase its investment in emerging digital tools.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 9, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
YEARS Diagnostic Algorithm Reduces CTPA Scans by Over 20 Percent in Cancer Patients
2026-07-12
West Nile and Usutu Viruses Detected in Wild Carnivore Populations in the Netherlands
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Scroll to Top